EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Therapeutics of Charcot neuroarthropathy and pharmacological mechanisms: A bone metabolism perspective

Liang Liu, Qiong Wang, Yan Zhang, Jingqi Liang, Peilong Liu, Hongmou Zhao

Frontiers in Pharmacology · 12.04.2023 · 14

DOI: 10.3389/fphar.2023.1160278 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Pharmacology, online erschienen am 12.04.2023. Verfasst von Liang Liu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Foot and Ankle Surgery, Honghui Hospital of Xi'an Jiaotong University, Xi'an, China. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Charcot neuroarthropathy (CN) is a chronic, destructive, and painless damage of the skeletal system that affects the life quality of patients. CN, with an unclear mechanism, is characterized with invasive destruction of bones and a serious abnormality of bone metabolism. Unfortunately, development of an effective prevention and treatment strategy for CN is still a great challenge. Of note, recent studies providing an insight into the molecular mechanisms of bone metabolism and homeostasis have propelled development of novel CN therapeutic strategies. Therefore, this review aims to shed light on the pathogenesis, diagnosis, and treatment of CN. In particular, we highlight the eminent role of the osteoprotegerin (OPG)-receptor activator of nuclear factor-κB (RANK)-RANK ligand (RANKL) system in the development of CN. Furthermore, we summarize and discuss the diagnostic biomarkers of CN as well as the potential pharmacological mechanisms of current treatment regimens from the perspective of bone metabolism. We believe that this review will enhance the current state of knowledge on the diagnosis, prevention, and therapeutic efficacy of CN.

Schlagwörter

Stichwörter der Autor:innen

Charcot neuroarthropathyRANKLbone metabolismpharmacologytherapeutics

Autor:innen und Institutionen

  • Department of Foot and Ankle Surgery, Honghui Hospital of Xi'an Jiaotong University, Xi'an, China.

Zitieren

APA

Liu, L., Wang, Q., Zhang, Y., Liang, J., Liu, P., & Zhao, H. (2023). Therapeutics of Charcot neuroarthropathy and pharmacological mechanisms: A bone metabolism perspective. Frontiers in Pharmacology, 14. https://doi.org/10.3389/fphar.2023.1160278

Vancouver

Liu L, Wang Q, Zhang Y, Liang J, Liu P, Zhao H. Therapeutics of Charcot neuroarthropathy and pharmacological mechanisms: A bone metabolism perspective. Frontiers in Pharmacology. 2023;14. doi:10.3389/fphar.2023.1160278

BibTeX
@article{Liu2023,
  author = {Liu, Liang and Wang, Qiong and Zhang, Yan and Liang, Jingqi and Liu, Peilong and Zhao, Hongmou},
  title = {Therapeutics of Charcot neuroarthropathy and pharmacological mechanisms: A bone metabolism perspective},
  journal = {Frontiers in Pharmacology},
  year = {2023},
  volume = {14},
  doi = {10.3389/fphar.2023.1160278}
}
Kostenlos starten →